Search
for
Sort by
Research 211–240 of 1000+
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Specific inhibition of FGF5-induced cell proliferation by RNA aptamers
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Clinical use of 5α-reductase inhibitors
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- A REVIEW ON PHYTOPHARMACOLOGICAL SIGNIFICANCE OF ECLIPTA ALBA
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
- New Drugs: Dutasteride
- The human keratins: biology and pathology
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Dermatological adverse events with taxane chemotherapy
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Drug eruptions in dermatology
- Androgen Receptor Ligands: Agonists and Antagonists
- Vesicular Carriers for Follicular Drug Delivery
- Treatment options for alopecia: an update, looking to the future
- Male androgenetic alopecia (Part II)
- Measurement of Steroid Hormones in Hair: an Analysis of Hormone Dynamics in Hair Follicles